Literature DB >> 30483874

Adult attention-deficit/hyperactivity disorder, risky substance use and substance use disorders: a follow-up study among young men.

Natalia Estévez-Lamorte1,2,3,4, Simon Foster5,6,7, Dominique Eich-Höchli8, Franz Moggi9, Gerhard Gmel10,11,12,13, Meichun Mohler-Kuo14,5,6,7.   

Abstract

We investigated whether adult attention-deficit/hyperactivity disorder (ADHD) predicts risky substance use and substance use disorders (SUDs), and its impact on the course of these problematic substance use patterns. Our sample included 4975 Swiss men (mean age 20 ± 1.2 years) who participated in the baseline and 15-month follow-up assessments of the Cohort Study on Substance Use Risk Factors. We examined: (1) the contribution of ADHD, as assessed at baseline, on the risky use of alcohol, nicotine and cannabis, and their corresponding use disorders (AUD, NUD, CUD) at follow-up; and (2) the association between ADHD and the course of outcomes (i.e., absence, initiation, maturing out, persistence) over 15 months. All analyses were adjusted for socio-demographics and co-morbidity. Men with ADHD were more likely to exhibit persistent risky alcohol and nicotine use, and to mature out of risky cannabis use. ADHD at baseline was positively linked to AUD and negatively to CUD at follow-up, but not to NUD. For all SUDs, ADHD had a positive association with use persistence and maturing out. Comparing these two trajectories revealed that early age of alcohol use initiation distinguished between persistence and maturing out of AUD, while the course of NUD and CUD was related to ADHD symptoms and SUD severity at baseline. Already in their early twenties, men with ADHD are especially likely to exhibit persistent problematic substance use patterns. Substance-specific prevention strategies, particularly implemented before early adulthood, may be crucial to reducing the development and persistence of pathological patterns in such individuals.

Entities:  

Keywords:  Adult attention-deficit/hyperactivity disorder; Alcohol; Cannabis; Nicotine; Risky substance use; Substance use disorder

Year:  2018        PMID: 30483874     DOI: 10.1007/s00406-018-0958-3

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  6 in total

1.  Screened Attention Deficit/Hyperactivity Disorder as a Predictor of Substance Use Initiation and Escalation in Early Adulthood and the Role of Self-Reported Conduct Disorder and Sensation Seeking: A 5-Year Longitudinal Study with Young Adult Swiss Men.

Authors:  Franz Moggi; Deborah Schorno; Leila Maria Soravia; Meichun Mohler-Kuo; Natialia Estévez-Lamorte; Joseph Studer; Gerhard Gmel
Journal:  Eur Addict Res       Date:  2020-06-19       Impact factor: 3.015

Review 2.  [ADHD in adult patients with substance use disorders].

Authors:  Mathias Luderer; Falk Kiefer; Andreas Reif; Franz Moggi
Journal:  Nervenarzt       Date:  2019-09       Impact factor: 1.214

3.  ADGRL3 (LPHN3) variants predict substance use disorder.

Authors:  Mauricio Arcos-Burgos; Jorge I Vélez; Ariel F Martinez; Marta Ribasés; Josep A Ramos-Quiroga; Cristina Sánchez-Mora; Vanesa Richarte; Carlos Roncero; Bru Cormand; Noelia Fernández-Castillo; Miguel Casas; Francisco Lopera; David A Pineda; Juan D Palacio; Johan E Acosta-López; Martha L Cervantes-Henriquez; Manuel G Sánchez-Rojas; Pedro J Puentes-Rozo; Brooke S G Molina; Margaret T Boden; Deeann Wallis; Brett Lidbury; Saul Newman; Simon Easteal; James Swanson; Hardip Patel; Nora Volkow; Maria T Acosta; Francisco X Castellanos; Jose de Leon; Claudio A Mastronardi; Maximilian Muenke
Journal:  Transl Psychiatry       Date:  2019-01-29       Impact factor: 6.222

4.  Efficacy of cognitive behavioural therapy in medicated adults with attention-deficit/hyperactivity disorder in multiple dimensions: a randomised controlled trial.

Authors:  Mei-Rong Pan; Shi-Yu Zhang; Sun-Wei Qiu; Lu Liu; Hai-Mei Li; Meng-Jie Zhao; Min Dong; Fei-Fei Si; Yu-Feng Wang; Qiu-Jin Qian
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-02-22       Impact factor: 5.270

5.  Interaction between behavioral inhibition and neural alcohol cue-reactivity in ADHD and alcohol use disorder.

Authors:  S Vollstädt-Klein; S Gerhardt; A Lee; A Strosche; G Sharafi; R Nuriyeva; J Seidt; O Hennig; B Alm; D Hermann; W H Sommer; F Kiefer; M Luderer; E Sobanski
Journal:  Psychopharmacology (Berl)       Date:  2020-04-13       Impact factor: 4.530

6.  Mind the treatment gap: the prevalence of common mental disorder symptoms, risky substance use and service utilization among young Swiss adults.

Authors:  Laura Werlen; Milo A Puhan; Markus A Landolt; Meichun Mohler-Kuo
Journal:  BMC Public Health       Date:  2020-09-29       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.